GE Healthcare Technologies, Inc. (GEHC)
69.57
-0.78
(-1.11%)
USD |
NASDAQ |
Oct 16, 16:00
69.55
-0.02
(-0.03%)
After-Hours: 20:00
GE Healthcare Technologies Research and Development Expense (Annual) : 1.26B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.26B |
| December 31, 2024 | 1.311B |
| December 31, 2023 | 1.205B |
| December 31, 2022 | 1.026B |
| Date | Value |
|---|---|
| December 31, 2021 | 816.00M |
| December 31, 2020 | 810.00M |
| December 31, 2019 | 833.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Butterfly Network, Inc. | 36.26M |
| Abbott Laboratories | 2.889B |
| Boston Scientific Corp. | 2.052B |
| Intuitive Surgical, Inc. | 1.312B |
| Stryker Corp. | 1.567B |